SpyGlass Pharma Announces New Add-on Category III CPT Code for Its Innovative BIM-IOL System
SpyGlass Pharma announced that the AMA CPT Editorial Panel approved a new add-on Category III CPT code (+X659T) for its BIM-IOL System. This code covers the attachment and insertion of the intraocular drug delivery implant during routine cataract surgery, establishing a specific reimbursement pathway for the novel technology.
Key figures
- Drug Name
- Bimatoprost Drug Pad-IOL System (BIM-IOL System)
- Phase Of Trial
- Phase 3
- Cpt code
- +X659T
- Enrollment completion
- 2027
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.